Cargando…

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C

BACKGROUND: Evaluating the progression of hepatic fibrosis in chronic hepatitis C (CHC) is critical, and identifying a predictive biomarker for fibrosis will be helpful for implementing personalized surveillance of hepatocellular carcinoma after the elimination of hepatitis C virus by antiviral ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuura, Kentaro, Aizawa, Nobuhiro, Enomoto, Hirayuki, Nishiguchi, Shuhei, Toyoda, Hidenori, Kumada, Takashi, Iio, Etsuko, Ito, Kyoko, Ogawa, Shintaro, Isogawa, Masanori, Alter, Harvey J, Tanaka, Yasuhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231525/ https://www.ncbi.nlm.nih.gov/pubmed/30443558 http://dx.doi.org/10.1093/ofid/ofy268

Ejemplares similares

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection
por: Suzuki, Takanori, et al.
Publicado: (2021)

Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases
por: Yoh, Kazunori, et al.
Publicado: (2020)

Complex structural variations in non-human primate hepatitis B virus
por: Nagura, Yoshihito, et al.
Publicado: (2021)

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
por: Aizawa, Nobuhiro, et al.
Publicado: (2013)

Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
por: Nagura, Yoshihito, et al.
Publicado: (2022)

Characterization of hepatitis B virus with complex structural variations
por: Fujiwara, Kei, et al.
Publicado: (2018)

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan
por: Toyoda, Hidenori, et al.
Publicado: (2019)

Serum Zinc Level Grading System: A Useful Model for Composite Hepatic Events in Hepatitis C Virus-Associated Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2018)

Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture
por: Hamada-Tsutsumi, Susumu, et al.
Publicado: (2020)

Improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis
por: Iwata, Kazunari, et al.
Publicado: (2014)

Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis
por: Yuri, Yukihisa, et al.
Publicado: (2019)

Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Anthropometric Measurements and Frailty in Patients with Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection
por: Hamada-Tsutsumi, Susumu, et al.
Publicado: (2015)

Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients
por: Takashima, Tomoyuki, et al.
Publicado: (2016)

Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study
por: Nishiguchi, Shuhei, et al.
Publicado: (2013)

B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

A New Metabolism-Related Index Correlates with the Degree of Liver Fibrosis in Hepatitis C Virus-Positive Patients
por: Enomoto, Hirayuki, et al.
Publicado: (2015)

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease
por: Takata, Ryo, et al.
Publicado: (2017)

Effect of physical exercise on sarcopaenia in patients with overt hepatic encephalopathy: a study protocol for a randomised controlled trial
por: Yoh, Kazunori, et al.
Publicado: (2017)

Influence of Genes Suppressing Interferon Effects in Peripheral Blood Mononuclear Cells during Triple Antiviral Therapy for Chronic Hepatitis C
por: Iijima, Sayuki, et al.
Publicado: (2015)

An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients
por: Enomoto, Hirayuki, et al.
Publicado: (2014)

Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis
por: Hasegawa, Kunihiro, et al.
Publicado: (2016)

Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Yoh, Kazunori, et al.
Publicado: (2017)

Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma
por: Enomoto, Hirayuki, et al.
Publicado: (2015)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Corrigendum to “An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients”
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Factors influencing distant recurrence of hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization therapy in patients with hepatitis C
por: Nojiri, Shunsuke, et al.
Publicado: (2011)

Diagnosis of Spontaneous Bacterial Peritonitis and an In Situ Hybridization Approach to Detect an “Unidentified” Pathogen
por: Enomoto, Hirayuki, et al.
Publicado: (2014)

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment
por: Sakai, Yoshiyuki, et al.
Publicado: (2014)

Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene
por: Watanabe, Tsunamasa, et al.
Publicado: (2013)

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b8v2m4v3giab2jf4buk5u60jpc